{
    "hands_on_practices": [
        {
            "introduction": "A core skill in evidence-based medicine is the ability to interpret a screening test result in the context of a specific patient population. While a test's intrinsic characteristics like sensitivity and specificity are fixed, the probability that a positive test indicates true disease—the positive predictive value—is highly dependent on the condition's prevalence. This exercise  will guide you through deriving this crucial value from first principles, reinforcing your understanding of how to translate abstract test performance into clinically meaningful probabilities for your patient.",
            "id": "4500123",
            "problem": "A 30-year-old asymptomatic patient presents for a preventive health evaluation during a well-woman visit. She undergoes screening for a specific gynecologic condition using a laboratory test whose performance characteristics in this clinic population are known: sensitivity is $0.90$, specificity is $0.95$, and the target condition’s prevalence in this screened population is $0.02$. Using only the foundational definitions of conditional probability, sensitivity, specificity, and disease prevalence, and without invoking any pre-memorized screening formula, derive from first principles an analytic expression for the positive predictive value (the probability of having the condition given a positive test) and then compute its value for this patient population.\n\nYou must:\n- Start from the core definitions of $P(A \\mid B)$ and the law of total probability.\n- Treat sensitivity as $P(T^{+} \\mid D)$, specificity as $P(T^{-} \\mid D^{c})$, and prevalence as $P(D)$, where $D$ denotes the presence of disease and $T^{+}$ denotes a positive test.\n- Compute the positive predictive value $P(D \\mid T^{+})$ as a decimal.\n\nRound your final numerical answer to four significant figures. Express your answer as a decimal (do not use a percentage sign).",
            "solution": "The problem as stated is valid. It is scientifically sound, well-posed, and objective. All necessary data for a unique solution are provided. The problem is a standard application of conditional probability in the context of medical diagnostics. We will proceed to derive the solution from first principles.\n\nLet $D$ be the event that a patient has the specific gynecologic condition, and let $D^c$ be the complementary event that the patient does not have the condition. Let $T^+$ be the event that the screening test result is positive, and $T^-$ be the event that the result is negative.\n\nThe givens from the problem statement are translated into probabilistic terms as follows:\n- The prevalence of the condition, $P(D)$, is $0.02$.\n- The sensitivity of the test, which is the probability of a positive test given the person has the disease, is $P(T^+ \\mid D) = 0.90$.\n- The specificity of the test, which is the probability of a negative test given the person does not have the disease, is $P(T^- \\mid D^c) = 0.95$.\n\nOur objective is to calculate the positive predictive value (PPV), which is the probability that a patient has the condition given that she has received a positive test result. This corresponds to the conditional probability $P(D \\mid T^+)$.\n\nWe begin with the fundamental definition of conditional probability:\n$$P(D \\mid T^+) = \\frac{P(D \\cap T^+)}{P(T^+)}$$\nwhere $P(D \\cap T^+)$ is the joint probability of having the disease and testing positive.\n\nFirst, we will find an expression for the numerator, $P(D \\cap T^+)$. We can use the definition of conditional probability for the sensitivity, $P(T^+ \\mid D)$:\n$$P(T^+ \\mid D) = \\frac{P(T^+ \\cap D)}{P(D)}$$\nRearranging this equation gives us an expression for the joint probability:\n$$P(D \\cap T^+) = P(T^+ \\mid D) \\cdot P(D)$$\nThe values on the right-hand side are given as the sensitivity and the prevalence, respectively.\n\nNext, we will find an expression for the denominator, $P(T^+)$. This is the overall probability of receiving a positive test result. To find this, we apply the Law of Total Probability. The event $T^+$ can be partitioned into two mutually exclusive events: testing positive with the disease ($T^+ \\cap D$) and testing positive without the disease ($T^+ \\cap D^c$).\n$$P(T^+) = P(T^+ \\cap D) + P(T^+ \\cap D^c)$$\nWe have already found an expression for the first term: $P(T^+ \\cap D) = P(T^+ \\mid D) \\cdot P(D)$.\nFor the second term, $P(T^+ \\cap D^c)$, we again use the definition of conditional probability:\n$$P(T^+ \\cap D^c) = P(T^+ \\mid D^c) \\cdot P(D^c)$$\nTo evaluate this, we need $P(D^c)$ and $P(T^+ \\mid D^c)$.\n$P(D^c)$ is the probability of not having the disease, which is the complement of the prevalence:\n$$P(D^c) = 1 - P(D)$$\n$P(T^+ \\mid D^c)$ is the probability of a positive test given the absence of disease. This is the false positive rate. We are given the specificity, $P(T^- \\mid D^c)$, which is the probability of a negative test in a disease-free individual. Since a test result can only be positive or negative, these are complementary events for a person in a given state of health. Therefore:\n$$P(T^+ \\mid D^c) + P(T^- \\mid D^c) = 1$$\n$$P(T^+ \\mid D^c) = 1 - P(T^- \\mid D^c)$$\nSubstituting these back into the expression for $P(T^+)$, we get:\n$$P(T^+) = \\left( P(T^+ \\mid D) \\cdot P(D) \\right) + \\left( (1 - P(T^- \\mid D^c)) \\cdot (1 - P(D)) \\right)$$\n\nNow, we can assemble the complete analytical expression for the PPV, $P(D \\mid T^+)$, by substituting the expressions for the numerator and denominator:\n$$P(D \\mid T^+) = \\frac{P(T^+ \\mid D) \\cdot P(D)}{P(T^+ \\mid D) \\cdot P(D) + P(T^+ \\mid D^c) \\cdot P(D^c)}$$\n$$P(D \\mid T^+) = \\frac{P(T^+ \\mid D) \\cdot P(D)}{\\left( P(T^+ \\mid D) \\cdot P(D) \\right) + \\left( (1 - P(T^- \\mid D^c)) \\cdot (1 - P(D)) \\right)}$$\nThis expression is derived from first principles as required.\n\nNow we substitute the given numerical values:\n- $P(D) = 0.02$\n- $P(T^+ \\mid D) = 0.90$\n- $P(T^- \\mid D^c) = 0.95$\n\nFirst, calculate the necessary intermediate probabilities:\n- The probability of not having the disease: $P(D^c) = 1 - P(D) = 1 - 0.02 = 0.98$.\n- The false positive rate: $P(T^+ \\mid D^c) = 1 - P(T^- \\mid D^c) = 1 - 0.95 = 0.05$.\n\nNext, calculate the value of the numerator of the PPV expression. This is the probability of a true positive result in the population:\n$$P(D \\cap T^+) = P(T^+ \\mid D) \\cdot P(D) = 0.90 \\times 0.02 = 0.018$$\n\nNext, calculate the value of the denominator. This is the total probability of a positive test:\n$$P(T^+) = P(D \\cap T^+) + P(D^c \\cap T^+)$$\nWe already have $P(D \\cap T^+) = 0.018$. The second term is the probability of a false positive result in the population:\n$$P(D^c \\cap T^+) = P(T^+ \\mid D^c) \\cdot P(D^c) = 0.05 \\times 0.98 = 0.049$$\nSo, the total probability of a positive test is:\n$$P(T^+) = 0.018 + 0.049 = 0.067$$\n\nFinally, we compute the positive predictive value:\n$$P(D \\mid T^+) = \\frac{P(D \\cap T^+)}{P(T^+)} = \\frac{0.018}{0.067}$$\n$$P(D \\mid T^+) \\approx 0.268656716...$$\n\nRounding the result to four significant figures, we get $0.2687$.\nThus, for a patient in this population who tests positive, the probability of actually having the condition is approximately $0.2687$.",
            "answer": "$$\\boxed{0.2687}$$"
        },
        {
            "introduction": "Building on the fundamentals of predictive value, we now turn to a more direct tool used in clinical practice: the likelihood ratio. Likelihood ratios provide an elegant and efficient way to update a patient's pre-test risk to a post-test risk, a cornerstone of modern risk-based management. In this practice , you will use a given positive likelihood ratio from an HPV test to quantify a patient's updated risk of cervical neoplasia and apply a clinical threshold to determine the appropriate next step in management.",
            "id": "4500129",
            "problem": "A patient aged $32$ years presents for a routine well-woman visit. In this clinic population, the pretest probability for cervical intraepithelial neoplasia grade $2$ or worse (CIN2+) is estimated at $0.05$ for individuals with similar age and screening history. She undergoes primary human papillomavirus (HPV) testing. The test returns a positive result, and the positive likelihood ratio (LR+, defined as the ratio of sensitivity to one minus specificity) for this HPV assay in detecting CIN2+ is $10$.\n\nStarting from the definitions of probability, odds, and likelihood ratio, derive the post-test probability of CIN2+ given the positive HPV test. Then, using the clinic’s risk-based management policy that recommends diagnostic colposcopy if the immediate post-test probability of CIN2+ is at least $0.20$ and otherwise recommends surveillance with repeat testing at $12$ months, translate the computed post-test probability into the appropriate management action.\n\nExpress the final post-test probability as a decimal fraction, and round your answer to four significant figures.",
            "solution": "The problem is first validated against the specified criteria.\n\n### Step 1: Extract Givens\n- Patient age: $32$ years\n- Pretest probability for cervical intraepithelial neoplasia grade $2$ or worse (CIN2+): $P(\\text{CIN2+}) = 0.05$\n- Positive likelihood ratio (LR+) for the human papillomavirus (HPV) assay: $LR+ = 10$\n- Definition of positive likelihood ratio: $LR+ = \\frac{\\text{sensitivity}}{1 - \\text{specificity}}$\n- Management policy threshold: Diagnostic colposcopy is recommended if the immediate post-test probability of CIN2+ is at least $0.20$. Surveillance with repeat testing at $12$ months is recommended otherwise.\n- Test result: Positive HPV test.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed as valid for the following reasons:\n- **Scientifically Grounded:** The problem uses fundamental principles of Bayesian inference, specifically the application of likelihood ratios to update probabilities, which is a cornerstone of evidence-based medicine and medical diagnostics. The clinical context (cervical cancer screening), terminology (CIN2+, HPV testing, colposcopy), and values (pretest probability, LR+) are realistic and standard within the field of gynecology.\n- **Well-Posed:** The problem provides all necessary information to calculate a unique solution. It clearly defines the initial state (pretest probability), the new evidence (positive test result with its associated LR+), and the question (calculate the post-test probability and determine the subsequent management action based on a given threshold).\n- **Objective:** The language is clinical and quantitative, devoid of subjective or opinion-based statements.\n\nThe problem does not exhibit any flaws such as scientific unsoundness, incompleteness, contradiction, or ambiguity. Therefore, a solution can be derived.\n\n### Step 3: Verdict and Action\nThe problem is valid. The solution process will proceed.\n\nThe solution requires calculating the post-test probability of CIN2+ given a positive HPV test, starting from the pre-test probability and the positive likelihood ratio. This is most elegantly achieved using the odds-likelihood ratio formulation of Bayes' theorem.\n\nFirst, we define the relationship between probability, $P$, and odds, $O$. The odds of an event are the ratio of the probability that the event will occur to the probability that it will not occur.\n$$O = \\frac{P}{1 - P}$$\nConversely, the probability can be derived from the odds:\n$$P = \\frac{O}{1 + O}$$\n\nThe pre-test probability of CIN2+, denoted as $P_{\\text{pre}}$, is given as $0.05$. We can calculate the pre-test odds, $O_{\\text{pre}}$, as follows:\n$$O_{\\text{pre}} = \\frac{P_{\\text{pre}}}{1 - P_{\\text{pre}}} = \\frac{0.05}{1 - 0.05} = \\frac{0.05}{0.95} = \\frac{5}{95} = \\frac{1}{19}$$\n\nBayes' theorem in its odds-likelihood form states that the post-test odds, $O_{\\text{post}}$, are the product of the pre-test odds and the likelihood ratio ($LR$). Since the test result is positive, we use the positive likelihood ratio, $LR+$.\n$$O_{\\text{post}} = O_{\\text{pre}} \\times LR+$$\nWe are given $LR+ = 10$. Substituting the values:\n$$O_{\\text{post}} = \\frac{1}{19} \\times 10 = \\frac{10}{19}$$\n\nNow, we convert the post-test odds back into a post-test probability, $P_{\\text{post}}$. This is the probability of CIN2+ given the positive test result.\n$$P_{\\text{post}} = \\frac{O_{\\text{post}}}{1 + O_{\\text{post}}} = \\frac{\\frac{10}{19}}{1 + \\frac{10}{19}} = \\frac{\\frac{10}{19}}{\\frac{19}{19} + \\frac{10}{19}} = \\frac{\\frac{10}{19}}{\\frac{29}{19}} = \\frac{10}{29}$$\n\nTo apply the clinic's management policy, we must express this probability as a decimal.\n$$P_{\\text{post}} = \\frac{10}{29} \\approx 0.344827586...$$\n\nThe problem requires rounding the final post-test probability to four significant figures.\n$$P_{\\text{post}} \\approx 0.3448$$\n\nThe final step is to apply the clinic's risk-based management policy. The policy states that diagnostic colposcopy is recommended if the immediate post-test probability of CIN2+ is at least $0.20$.\nOur calculated post-test probability is $0.3448$.\nSince $0.3448 \\geq 0.20$, the condition for colposcopy is met.\n\nTherefore, the appropriate management action is to recommend a diagnostic colposcopy. The computed post-test probability is $0.3448$.",
            "answer": "$$\\boxed{0.3448}$$"
        },
        {
            "introduction": "Screening strategies often involve combining multiple tests to maximize detection, such as adding ultrasound to mammography for women with dense breasts. However, this approach can have important consequences for the rate of false positives, which can lead to unnecessary interventions and patient anxiety. This final exercise  challenges you to quantify the impact of an adjunct test on the overall false-positive rate, highlighting the critical trade-offs involved in designing and implementing effective screening protocols.",
            "id": "4500141",
            "problem": "A $45$-year-old patient with heterogeneously dense breasts presents for a preventive well-woman visit to discuss breast cancer screening. In this population, you may reasonably model single-episode screening test behavior using the core definitions of diagnostic test performance: specificity is $P(\\text{test negative} \\mid \\text{no disease})$ and the false-positive rate is $P(\\text{test positive} \\mid \\text{no disease}) = 1 - \\text{specificity}$. Suppose the screening strategy is as follows: screening mammography is performed for all patients; in patients with dense breasts, adjunct handheld ultrasound is added, and a recall is triggered if either test is positive.\n\nUnder scientifically plausible test characteristics for non-diseased women with dense breasts, let the specificity of mammography be $S_{M} = 0.92$ and the specificity of adjunct ultrasound be $S_{U} = 0.90$. Assume conditional independence of test results given non-disease. Using only the fundamental definitions above and standard probability rules, derive the expression for the false-positive probability of the combined strategy and compute the relative change in the false-positive rate when adding ultrasound compared with mammography alone, defined as\n$$R = \\frac{\\text{false-positive probability with mammography plus ultrasound}}{\\text{false-positive probability with mammography alone}}.$$\nRound your final numeric answer for $R$ to four significant figures. Express the final result as a pure number without any unit or percentage sign.",
            "solution": "The problem statement is evaluated for validity prior to attempting a solution.\n\n### Step 1: Extract Givens\n- Population: Non-diseased women with dense breasts.\n- Definition of specificity: $P(\\text{test negative} \\mid \\text{no disease})$.\n- Definition of false-positive rate: $P(\\text{test positive} \\mid \\text{no disease}) = 1 - \\text{specificity}$.\n- Screening strategy: Mammography is performed. Adjunct handheld ultrasound is added. A recall is triggered if either test is positive.\n- Specificity of mammography: $S_{M} = 0.92$.\n- Specificity of adjunct ultrasound: $S_{U} = 0.90$.\n- Assumption: Conditional independence of test results given non-disease.\n- Quantity to be computed: Relative change in the false-positive rate, $R = \\frac{\\text{false-positive probability with mammography plus ultrasound}}{\\text{false-positive probability with mammography alone}}$.\n- Required precision: Round the final numeric answer for $R$ to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, using standard definitions from medical statistics and epidemiology (specificity, false-positive rate). The clinical scenario, including the use of adjunct ultrasound for dense breasts and the specified specificity values, is plausible and consistent with real-world medical practice. The problem is well-posed, providing all necessary information, definitions, and assumptions (conditional independence) to derive a unique solution. The language is objective and precise. The problem is a formalizable probability calculation and does not violate any of the invalidity criteria.\n\n### Step 3: Verdict and Action\nThe problem is deemed valid. A complete solution will now be provided.\n\nLet $D^c$ denote the event that a woman is non-diseased. The problem is conditioned entirely on this event. Let $M^+$ and $M^-$ be the events of a positive and negative mammogram, respectively. Similarly, let $U^+$ and $U^-$ be the events of a positive and negative ultrasound, respectively.\n\nThe givens can be stated in probabilistic terms:\n- Specificity of mammography: $S_M = P(M^- \\mid D^c) = 0.92$.\n- Specificity of ultrasound: $S_U = P(U^- \\mid D^c) = 0.90$.\n\nThe false-positive probability (FPP), or false-positive rate, of a test is the probability of a positive result, given no disease.\n\nFor mammography alone, the false-positive probability, $\\text{FPP}_M$, is:\n$$ \\text{FPP}_M = P(M^+ \\mid D^c) = 1 - P(M^- \\mid D^c) = 1 - S_M $$\n\nThe combined screening strategy triggers a recall if either test is positive. This corresponds to the union of events, $M^+ \\cup U^+$. The false-positive probability of the combined strategy, $\\text{FPP}_{\\text{comb}}$, is therefore $P(M^+ \\cup U^+ \\mid D^c)$.\n\nTo calculate this probability, it is more direct to first consider the complementary event: that the combined test is negative. For the combined test to be negative, both the mammogram and the ultrasound must be negative. This corresponds to the intersection of events, $M^- \\cap U^-$.\n\nThe specificity of the combined strategy, $S_{\\text{comb}}$, is the probability that both tests are negative, given no disease:\n$$ S_{\\text{comb}} = P(M^- \\cap U^- \\mid D^c) $$\n\nThe problem states that the test results are conditionally independent given non-disease. This allows us to write:\n$$ S_{\\text{comb}} = P(M^- \\mid D^c) \\times P(U^- \\mid D^c) = S_M S_U $$\n\nThe false-positive probability of the combined strategy is the complement of its specificity:\n$$ \\text{FPP}_{\\text{comb}} = 1 - S_{\\text{comb}} = 1 - S_M S_U $$\n\nWe are asked to compute the relative change in the false-positive rate, $R$, defined as the ratio of the combined FPP to the FPP of mammography alone:\n$$ R = \\frac{\\text{FPP}_{\\text{comb}}}{\\text{FPP}_M} $$\n\nSubstituting the derived expressions:\n$$ R = \\frac{1 - S_M S_U}{1 - S_M} $$\n\nNow, substitute the given numerical values, $S_M = 0.92$ and $S_U = 0.90$:\nThe false-positive probability for mammography alone is:\n$$ \\text{FPP}_M = 1 - 0.92 = 0.08 $$\nThe specificity of the combined strategy is:\n$$ S_{\\text{comb}} = S_M S_U = 0.92 \\times 0.90 = 0.828 $$\nThe false-positive probability of the combined strategy is:\n$$ \\text{FPP}_{\\text{comb}} = 1 - 0.828 = 0.172 $$\n\nFinally, we compute the ratio $R$:\n$$ R = \\frac{0.172}{0.08} = 2.15 $$\n\nThe problem requires the answer to be rounded to four significant figures. The exact value is $2.15$, which can be written as $2.150$ to show four significant figures.",
            "answer": "$$\\boxed{2.150}$$"
        }
    ]
}